Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells-Reference-Cited by-同舟云学术

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells

Published:2016-11-03 Issue:11 Volume:11 Page:e0165718
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Khan Mohammed I.^ORCID,Czarnecka Anna M.,Lewicki Sławomir,Helbrecht Igor,Brodaczewska Klaudia,Koch Irena,Zdanowski Robert,Król Magdalena,Szczylik Cezary

Funder

Fundacja na rzecz Nauki Polskiej

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference102 articles.

1. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies;LJ Costa;The oncologist,2007

2. Metastatic renal cell carcinoma;RC Flanigan;Current treatment options in oncology,2003

3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;RJ Motzer;The New England journal of medicine,2007

4. Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial;B Escudier;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2009

5. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial;BI Rini;Lancet,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression;Oncology Reviews;2024-07-18

2. Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma;BMC Cancer;2024-02-05

3. CD105 in the progression and therapy of renal cell carcinoma;Cancer Letters;2023-08

4. Clostridium perfringens Epsilon Toxin Binds to and Kills Primary Human Lymphocytes;Toxins;2023-06-29

5. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine;Cells;2023-03-24